A case of a squamous cell carcinoma of the conjunctiva is presented. The lesion was removed with recurrence in another conjunctival site. The patient received cycles of 5-Fluorouracil as adjuvant treatment to the surgical removal and presented unfavorable evolution, requiring orbital exenteration. Comments are made on the use of antimitotic drugs in the management of these lesions.
Neoplasms, squamous cell; Conjunctival neoplasms; Neoplasm recurrence, local; Orbit exenteration; Fluorouracil; Fluorouracil therapeutic use; Antimitotic agents; Humans; Male; Middle aged
